Lung Cancer Treatment Using Immune System Wins F.D.A. Approval ANDREW POLLACK Opdivo, from Bristol-Myers Squibb, which harnesses the body’s own immune system to attack tumors, was approved after strong results in a study. March 5, 2015 at 12:00AM http://nyti.ms/1FYwm19 The New York Times Business Day Lung Cancer, Drugs (Pharmaceuticals)

By ANDREW POLLACK via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1FYwm19 Lung Cancer Treatment Using Immune System Wins F.D.A. Approval March 5, 2015 at 12:00AM The New York Times